Company profile
INDVR Brands Inc.
OTC: CAAOF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Calgary, ABReports USD
#875 of 1,418 Healthcare companies by revenue58th-percentile growth
EA Score
——FH —DQ —GM —SS 18
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, revenue growth (YoY) · ↓ market scale, return on equity
Methodology →Revenue TTM
$1.0M
Rev growth YoY (TTM)
+221.2%
Net income (FY)
-$5.9M
Employees
3
as of 2026-08-30
Market cap
$3.0k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$943.7k$943.7k2020
Net income-$5.9M-$5.9M2020
Operating income-$4.8M-$4.8M2020
Total assets$7.4M$7.4M2020
Liabilities$6.0M$6.0M2020
Equity$1.5M$1.5M2020
Revenue trend
FY2016 – FY2020 · USD
FY16
FY17
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is INDVR Brands Inc.’s revenue?
INDVR Brands Inc. booked $943.7k in FY2020 revenue, growing 12% year over year — about the middle of the pack among Healthcare companies we track, at a -628.5% net margin.
Peers · Healthcare
Shattuck Labs, Inc.49DRavenQuest BioMed Inc.——The CannaBusiness Group, Inc.——Quick-Med Technologies, Inc.——ProKidney Corp.41DInVitro International76B+Key facts
CEOHugh Hemple
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersCalgary, AB
ExchangeOTC: CAAOF
Employees3
IPO date2019-02-27
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.